Compensation award — excluded from discretionary-purchase analysis.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Officer sold ~$177K of BMRN shares in the open market
Traded May 7, 2026 · Filed May 11, 2026
- ~$177K
- Reported value · 3,281 sh @ $53.85
- 52K
- Holds after · shares reported
- +6.3%
- stock since the trade · S&P 500 +5.9%, $54.12 → $57.54 on Oct 5
Why it stands out
BioMarin Pharmaceutical's Chief R&D Officer sold $177K of BioMarin Pharmaceutical shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- May 7, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- May 11, 2026
Officer$100K–$500K
Context
- Classification
open market sale
Code S — open-market or private sale
- Absolute commitment
~$176,682
Shares × reported transaction price
- Timing vs results
3 days after results of May 4, 2026, 91 days before results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
- Planned / mechanical clue